Amy McBride Wendell, Director at Axogen, Inc. (AXGN), bought 5,000 shares at $20.25 ($101K) on 2019-06-13, disclosed to the SEC on 2019-06-14.
Open-market purchase of $101k AXGN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| SOLV | BUY | 2026-03-11 | $100K | — | Filing → |
| AXGN | SELL | 2025-12-17 | $2.4M | — | Filing → |
| AXGN | SELL | 2025-06-11 | $43K | — | Filing → |